9DBT

Crystal structure of human astrovirus 1 capsid spike bound to human neonatal Fc receptor

Summary for 9DBT

• Entry DOI: 10.2210/pdb9dbt/pdb
• Descriptor: IgG receptor FcRn large subunit p51, Beta-2-microglobulin, Structural protein (3 entities in total)
• Functional Keywords: human astrovirus, capsid, human neonatal fc receptor, viral protein, viral protein-membrane protein complex, viral protein/membrane protein
• Biological source: Homo sapiens (human); More
• Total number of polymer chains: 12
• Total formula weight: 271418.13

Authors

Lentz, A.,DuBois, R.M. (deposition date: 2024-08-23, release date: 2025-09-03, Last modification date: 2025-11-19)

Primary citation

Lentz, A.,Lanning, S.,Iranpur, K.R.,Ricemeyer, L.,Arias, C.F.,DuBois, R.M.
Structure of the human astrovirus capsid spike in complex with the neonatal Fc receptor.
Nat Commun, 16:9621-9621, 2025

PubMed Abstract: Human astroviruses (HAstVs) are a leading cause of viral gastroenteritis in children worldwide. Recently the neonatal Fc receptor (FcRn) was identified as a receptor for HAstV, however the molecular basis for the FcRn-HAstV interaction remained unclear. Here, we report the crystal structure of FcRn bound to the HAstV capsid spike domain at 3.4 angstroms resolution. We show that all classical HAstV spikes bind to FcRn and we identify three conserved HAstV spike residues that mediate binding to FcRn. Using competition binding assays, we show that the HAstV spike competes with IgG for binding to FcRn. Additionally, we demonstrate that the FcRn inhibitor, nipocalimab, and anti-HAstV neutralizing monoclonal antibodies block HAstV spike binding to FcRn, revealing their neutralization mechanisms and supporting their therapeutic potential. Overall, our findings illuminate a crucial interaction in the HAstV life cycle, which may help to inform the development of a HAstV vaccine and antibody therapies.

PubMed: 41184319
DOI: 10.1038/s41467-025-65203-2

Experimental method

X-RAY DIFFRACTION (3.4 Å)